Home > Healthcare > Medical Devices > Diagnostic Devices > Colorectal Cancer Diagnostics Market

Colorectal Cancer Diagnostics Market Size

  • Report ID: GMI6924
  • Published Date: Oct 2023
  • Report Format: PDF

Colorectal Cancer Diagnostics Market Size

Colorectal Cancer Diagnostics Market size was valued at USD 13 billion in 2022 and is estimated to account for USD 30.2 billion by 2032. Colorectal cancer is one of the most prevalent cancer types and third most occurring cancer worldwide. According to the World Cancer Research Fund, there were an estimated 1.9 million new cases of colorectal cancer in 2020. This high incidence rate has fueled the demand for colorectal cancer diagnostics.

 

><Colorectal Cancer Diagnostics Market

To understand key trends  
Download Free Sample
 

The American Cancer Society recommends initiating the screening for CRC at the age of 45 instead of 50 as around 10% of colorectal cancer cases belongs to patients with less than 50 years of age. Thus, a considerable rise in the incidence and prevalence rate of early onset of CRC resulting in the demand for reliable diagnostics will stimulate the market growth. Also, detection at an early stage, the five-year survival rate can exceed to 90%, making early diagnosis crucial will promote market demand.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global colorectal cancer diagnostics industry value was USD 13 billion in 2022 and is estimated to account for USD 30.2 billion by 2032.

The hospitals segment garnered USD 5,335.9 million in the year 2022 and is expected to witness substantial growth through 2032 as awareness campaigns and educational efforts conducted at hospitals have significantly influenced public understanding of cancer screening's importance.

U.S. colorectal cancer diagnostics market accounted for USD 4.3 billion revenue size in 2022 and is predicted to witness substantial market growth through 2032 attributable to factors such as the presence of major business players, an increase in colorectal cancer screening procedures, etc.

Abbott Laboratories, BioMerieux SA, Becton, Dickinson, and Company, GE Healthcare, Qiagen N.V, F-Hoffmann-La Roche Ltd, Siemens Healthineers, Sysmex Corporation, Thermo Fischer Scientific, Hologic Inc., and Epigenomics AG.

Colorectal Cancer Diagnostics Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 172
  • Countries covered: 18
  • Pages: 125
 Download Free Sample